Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy (Q36011539)

11 August 2017

Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy (English)

1 reference

11 August 2017

1 reference

Lactobacillus reuteri

object named as

Lactobacillus reuteri

1 reference

Veronica Ojetti

1

1 reference

11 August 2017

Giovanni Bruno

2

1 reference

11 August 2017

Maria Elena Ainora

3

1 reference

11 August 2017

Giovanni Gigante

4

1 reference

11 August 2017

Gianluca Rizzo

5

1 reference

11 August 2017

Davide Roccarina

6

1 reference

11 August 2017

Antonio Gasbarrini

7

1 reference

11 August 2017

29 May 2012

1 reference

Gastroenterology research and practice

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

740381

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Health benefits of probiotics and prebiotics in women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Probiotics for the prevention of pediatric antibiotic-associated diarrhea

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Treatment of H. pylori infection: a review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Helicobacter pylori infection and the development of gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Accurate diagnosis of Helicobacter pylori. 13C-urea breath test

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: management of the disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Extradigestive manifestations of Helicobacter pylori gastric infection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Potential of using lactic acid bacteria for therapy and immunomodulation in man.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Proposal for use of a standard side effect scoring system in studies exploring Helicobacter pylori treatment regimens

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

Helicobacter pylori infection, anti-cagA antibodies and peptic ulcer: a case-control study in Italy.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

ERCP training: for the few, not for all

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy--a placebo-controlled, double-blind randomized pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

13C-urea breath test to assess Helicobacter pylori bacterial load

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effects of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effect of regular ingestion of Saccharomyces boulardii plus inulin or Lactobacillus acidophilus LB in children colonized by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368352

The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy

23 September 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F740381

Effect of a probiotic food as an adjuvant to triple therapy for eradication of Helicobacter pylori infection in children

21 January 2018

1 reference

12 December 2020

Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans

1 reference

12 December 2020

Treatment of Helicobacter pylori

1 reference

12 December 2020

Bacteriocins of gram-positive bacteria

1 reference

12 December 2020

Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children

1 reference

12 December 2020

Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model

1 reference

12 December 2020

Identifiers

DOI

10.1155/2012/740381

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22690211

1 reference